Gilead Sciences’ Post

Big pharma is planning on society continuing to rely on them instead of taking responsibility for their health… So far, we’ve done a great job of proving them right. It’s almost as if a huge swath of society has completely given up responsibility for their own life and handed it over to big pharma, healthcare, and the government. If you’re on the verge of doing the same, let me warn you head of time about what you’re giving up… You’re giving up your freedom and independence, because once you abdicate your health to big pharma, they’ll drain you for all you’re worth… You cannot be free and independent if you rely on someone or something else to take care of you…you are a part of the system…and where that system goes, you have to go with it. Taking responsibility for your life, on the other hand, means you are free from the chains of disease bondage…you choose your destiny. #takeresponsibility #takeresponsibilityforyouractions #itsyourchoice #youonlygetonelife #dothework

Our country’s IP system balances innovation and affordability, providing U.S. patients with choice and keeping medicine costs a small and stable 14% share of health care system spending. That’s why in the United States, we have access to more medicines than anywhere else while spurring brand to brand competition and ultimately lower cost generics and biosimilars. https://lnkd.in/dGgf-QyM

What's New to The Street... 💊 Big news in healthcare! Johnson & Johnson is set to acquire Intra-Cellular in a $15 billion deal, signaling a bold step into the future of mental health treatments. 🌟🧠 With pharmaceutical giants showing new enthusiasm for innovative therapies, this move could reshape the landscape of mental health care. What are your thoughts on this milestone moment? Share your insights below!💡 👉🏻Follow New To The Street for more! #JohnsonAndJohnson #MentalHealthInnovation #PharmaNews #HealthcareFuture #MentalWellness #Innovation #Businessupdate #Businessnews #Business #News #Newtothestreet

Watch my discussion with Dominique Harris about the upcoming Health Equity Summit cosponsored by Kearney and Chain Drug Review: https://lnkd.in/eaE5Z_fH Dominique Harris Kearney Chain Drug Review #healthequity #healthcare #pharmacy

Just released: Sun Life's annual High-cost claims and injectable drug trends analysis! 📊 Our comprehensive report of 60,000 stop-loss claims from a member database of six million people reveals significant insights for self-funded employers. From rising high-cost claims to changes in covered business, this report is essential for navigating the evolving landscape of healthcare costs. Read our press release to learn more: https://bit.ly/3Xl9JFF #HealthcareTrends #HealthAccess #SunLifeUS

🚑 Burnout in healthcare is a pressing issue that affects professionals' well-being and poses risks like drug diversion. To address this, effective communication and a culture of accountability are crucial. Prioritizing these aspects creates a supportive environment for staff well-being and quality care. 📺 We explore how to modernize your diversion program in an on-demand webinar with expert panelists. Watch it here: https://bit.ly/49cu2rT

To truly understand how medications work for people of different races, ethnicities and backgrounds, clinical trials need greater diversity. See the actions AbbVie is taking to increase representation by engaging communities and health care providers: https://lnkd.in/gCgwWabA #ClinicalTrialsDay #WeAreAbbVie

What's New to The Street... 💊 Big news in healthcare! Johnson & Johnson is set to acquire Intra-Cellular in a $15 billion deal, signaling a bold step into the future of mental health treatments. 🌟🧠 With pharmaceutical giants showing new enthusiasm for innovative therapies, this move could reshape the landscape of mental health care. What are your thoughts on this milestone moment? Share your insights below!💡 👉🏻Follow New To The Street for more! #JohnsonAndJohnson #MentalHealthInnovation #PharmaNews #HealthcareFuture #MentalWellness #Innovation #Businessupdate #Businessnews #Business #News #Newtothestreet

💵📈💊 According to Harvard Health Publishing, soaring medication costs are causing millions of Americans to skip out on their prescriptions. Addressing an urgent need for change, Mark Cuban's Mark Cuban Cost Plus Drug Company, PBC, PBC is taking charge, dismantling barriers to create a more accessible and affordable healthcare system. Check out our latest blog to explore the current hurdles to affordable prescriptions, Cost Plus Drug's transformative approach, and an insightful market access analysis.🔍 🔗 Link in the comments below! ⤵ #HealthcareAccess #CostPlusDrugs #MarkCuban

Today, we join the global call to ensure health for all. At Rusan Pharma, we embrace the core vision of Universal Health Coverage (UHC)—ensuring that quality healthcare reaches everyone, everywhere. Our journey is driven by a purpose: to innovate, inspire, and impact lives. From pioneering affordable medicines to delivering patient-focused solutions, we are proud to play a role in shaping a world where equitable healthcare is more than an aspiration—it’s a reality. Together, let’s break barriers, bridge gaps, and bring the vision of UHC to life. Because health isn’t just a privilege; it’s a fundamental right, and everyone deserves the opportunity to live healthier, fuller lives. #HealthForAll #UniversalHealthCoverage #InnovateInspireImpact #EquitableHealthcare #AffordableMedicines #PatientFocusedSolutions #GlobalHealth #RusanPharma #PainManagement #Deadiction #Parkinsonstreatment